HR 384 · 118th Congress 2023โ€“2025, ended

Protecting Life from Chemical Abortions Act

Latest action · Jan 27, 2023 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJan 17, 2023
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Protecting Life from Chemical Abortions Act

This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)

The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions.

In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers.

The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention.

The bill also generally prohibits the declaration of a public health emergency with respect to abortions.


Cosponsors 40

Members who signed on, in the order they did. Signatures ran from Jan 17, 2023 to Mar 29, 2024; 34 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-GAAndrew S. ClydeOriginalJan 17, 2023
R-IAAshley HinsonOriginalJan 17, 2023
R-TXAugust PflugerOriginalJan 17, 2023
R-GABarry LoudermilkOriginalJan 17, 2023
R-VABen ClineOriginalJan 17, 2023
R-MNBrad FinstadOriginalJan 17, 2023
R-OHBrad R. WenstrupOriginalJan 17, 2023
R-TXBrian BabinOriginalJan 17, 2023
R-FLBrian J. MastOriginalJan 17, 2023
R-FLDaniel WebsterOriginalJan 17, 2023
R-TNDiana HarshbargerOriginalJan 17, 2023
R-CADoug LaMalfaOriginalJan 17, 2023
R-CODoug LambornOriginalJan 17, 2023
R-WIGlenn GrothmanOriginalJan 17, 2023
R-TXJake EllzeyOriginalJan 17, 2023

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jan 17, 2023
Health Subcommittee
Referred Jan 27, 2023

Actions 3

Everything that happened, newest first.

  1. Jan 27, 2023Referred to the Subcommittee on Health.
  2. Jan 17, 2023Introduced in House
  3. Jan 17, 2023Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8

The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 12, January 17, 2023, page H244.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 118-48EXAMINING PROPOSALS THAT PROVIDE ACCESS TO CARE FOR PATIENTS AND SUPPORT RESEARCH FOR RARE DISEASES226 pagesEnergy and Commerce CommitteeJun 14, 2023

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To prohibit the use or declaration of a public health emergency with respect to abortion, and for other purposes.
Short Title(s) as Introduced
Protecting Life from Chemical Abortions Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jan 17, 2023Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.